Low willingness to vaccinate against herpes zoster in a Chinese metropolis
Background Herpes zoster vaccine (HZV) has been available in China’s mainland since June 2020. This study estimated willingness to receive HZV to characterize factors that may influence vaccination willingness. Methods We conducted a face-to-face questionnaire survey in adults aged 50–69 years in 13...
Main Authors: | Xinyue Lu, Jia Lu, Felicia Zhang, Abram L. Wagner, Liping Zhang, Kewen Mei, Baichu Guan, Yihan Lu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2021-11-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2021.1960137 |
Similar Items
-
Willingness to accept herpes zoster vaccines and the influencing factors in China
by: Binshan Jiang, et al.
Published: (2022-11-01) -
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
by: Yasmin Marra, et al.
Published: (2022-11-01) -
Disseminated herpes zoster with cauda equina symptoms
by: Corey J. Steinberg, et al.
Published: (2020-01-01) -
Herpes Zoster and Immunogenicity and Safety of Zoster Vaccines in Transplant Patients: A Narrative Review of the Literature
by: Lei Wang, et al.
Published: (2018-07-01) -
Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine
by: John Litt, et al.
Published: (2020-12-01)